COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,010 Articles (22,627 medRxiv, 8,383 bioRxiv)

Most recent first Previous |  Page 2029: Articles 20281-20290  | Next

Sustained expression of inflammatory monocytes and activated T cells in COVID-19 patients and recovered convalescent plasma donors
Trehanpati, N., Singh, R., Bajpai, M., Yadav, P., Maheshwari, A., Kumar, S., Agrawal, S., Kumar, J., Islam, M., Maras, J. S., Ramakrishna, G., Sarin, S. K.
10.1101/2020.11.17.20233668 — Posted: 2020-11-18
The decrease in hospitalizations for transient ischemic attack and ischemic stroke, especially in mild cases, during the COVID-19 epidemic in Japan.
Nagano, H., Takada, D., Shin, J.-h., Morishita, T., Kunisawa, S., Imanaka, Y.
10.1101/2020.11.17.20233692 — Posted: 2020-11-18
COVID-19: more than a little flu? Insights from the Swiss hospital-based surveillance of Influenza and COVID-19
Froehlich, G., De Kraker, M., Abbas, M., Keiser, O., Thiabaud, A., Roulens, M., Cusini, A., Flury, D., Schreiber, P., Buettcher, M., Corti, N., Vuichard-Gysin, D., Troillet, N., Sauser, J., Gaudenz, R., Damonti, L., Balmelli, C., Iten, A., Widmer, A., Harbarth, S., Sommerstein, R.
10.1101/2020.11.17.20233080 — Posted: 2020-11-18 Discussion: Onsite
Comparative Efficacy and Safety of Current Drugs against COVID-19: a Systematic Review and Net-work Meta Analysis
Li, Y., He, W.
10.1101/2020.11.16.20232884 — Posted: 2020-11-18
Detection of transmission change points during unlock-3 and unlock-4 measures controlling COVID-19 in India
Mandal, M., Mandal, S.
10.1101/2020.11.17.20233221 — Posted: 2020-11-18
Regular universal screening for SARS-CoV-2 infection may not allow reopening of society after controlling a pandemic wave
Bootsma, M. C., Kretzschmar, M. E., Rozhnova, G., Heesterbeek, H., kluytmans, J. J. A. J. W., Bonten, M. J.
10.1101/2020.11.18.20233122 — Posted: 2020-11-18 Discussion: Onsite
Accuracy of Rapid Point-of-Care Antibody Test in patients with suspected or confirmed COVID-19
Vancheeswaran, R., Willcox, M. L., Stuart, B., Knight, M., Kandil, H., Barlow, A., Patel, M. H., Stockham, J., O'Neill, A., Clark, T. L., Wilkinson, T., Little, P., Francis, N. A., Griffiths, G., Moore, M.
10.1101/2020.11.17.20233296 — Posted: 2020-11-18
Optimizing Vaccine Allocation to Combat the COVID-19 Pandemic
Bertsimas, D., Ivanhoe, J. K., Jacquillat, A., Li, M. L., Previero, A., Lami, O. S., Bouardi, H. T.
10.1101/2020.11.17.20233213 — Posted: 2020-11-18
COVIDStrategyCalculator: A standalone software to assess testing- and quarantine strategies for incoming travelers, contact person management and de-isolation
Van der Toorn, W., Oh, D.-Y., Bourquain, D., Michel, J., Krause, E., Nitsche, A., Von Kleist, M., Working group on SARS-CoV-2 Diagnostics at RKI
10.1101/2020.11.18.20233825 — Posted: 2020-11-18
COVID-19 Twitter-based analysis reveals differential concerns across areas with socioeconomic disparities
Su, Y., Venkat, A., Yadav, Y., Puglisi, L. B., Fodeh, S.
10.1101/2020.11.18.20233973 — Posted: 2020-11-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).